# US 2022/0009919 A1 · Preparation of n-monofluoroalkyl compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0009919 A1
- Document ID: US20220009919A1
- Status: Published application
- Kind: A1
- Application number: 17/174,155
- Filed: 2021-02-11
- Published: 2022-01-13
- Earliest claimed: 2009-12-17
- Assignees: Ge Healthcare Limited
- Applicants: GE Healthcare Limited
- Inventors: Lorenzo Williams; Gunnar Keilen; Jarle Andre Haugan
- Web page: https://patentgrep.com/patent/US20220009919A1

## CPC

- C07D 451/02: containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07F 7/00: Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F 7/2208: {Compounds having tin linked only to carbon, hydrogen and/or halogen}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

The present invention relates to an improved synthesis of N-monofluoroalkyl tropanes using fluoroalkyl iodide. The invention also provides the use of such method to prepare the non-radioactive tropane intermediate FP-CIT, and its subsequent conversion to the 123I-labelled radiopharmaceutical DaTSCAN™ (123I-ioflupane). Also provided is the use of fluoroalkyl iodide in the alkylation method of the invention.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

A method for preparing of a composition comprising a non-radioactive N-monofluoroalkyl tropane compound of Formula (IIIA):
having less than 1% of a transesterified impurity compound, analyzed by HPLC, of Formula (V):
wherein m is 2, 3, or 4, the method comprising alkylation of an amine of Formula (III):
with an alkylating agent of formula F—(CH2)mI, in the presence of a base and a solvent.

### Claim 23 (depends on 22)

The method of claim 22, wherein the alkylation comprises heating in the solvent.

### Claim 24 (depends on 22)

The method of claim 22, wherein the amount of the alkylating agent is 1.0-1.1 mole equivalents, and the amount of the base is 1.0-1.1 mole equivalents.

### Claim 25 (depends on 22)

The method of claim 22, wherein the heating is done at reflux for about 2 hours.

### Claim 26 (depends on 22)

The method of claim 22, wherein the solvent is toluene.

### Claim 27 (depends on 22)

The method of claim 22, wherein the amount of the amine of Formula (III) is 1 mole equivalent.

### Claim 28 (depends on 22)

The method of claim 22, wherein the amount of the alkylating agent is 1.1 mole equivalents, and the amount of the base is 1.1 mole equivalents.

### Claim 29 (depends on 22)

The method of claim 22, wherein the base is triethylamine.

### Claim 30 (depends on 22)

The method of claim 22, wherein the heating is at 50-120° C.

### Claim 31 (depends on 22)

The method of claim 22, wherein the alkylation comprises refluxing in the solvent.

### Claim 32 (depends on 22)

The method of claim 22, wherein the composition comprises at least 90% of the compound of Formula (IIIA).

### Claim 33 (depends on 22)

The method of claim 22, wherein the amount of the alkylating agent is 1.1 mole equivalents, the amount of the amine of Formula (III) is 1 mole equivalent, and the amount of the base is 1.1 mole equivalents.

### Claim 34 (depends on 22)

The method of claim 22, further comprising filtration and flash chromatographic purification of the N-monofluoroalkyl tropane compound of Formula (IIIA).
